Skip to search formSkip to main contentSkip to account menu

CI-990

National Institutes of Health

Related topics

Related topics

1 relation
PD 131112

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Efficacy of quinolones in preventing Staphylococcus aureus-induced abscess in mice.
The new fluoroquinolones clinafloxacin, CI-990 (PD 131112/PD 131628), sparfloxacin, and PD 138312 were bactericidal against… 
1994
1994
Quinolone therapy in the prevention of endogenous and exogenous infection after irradiation.
The effect of oral therapy with 6 quinolones, lomefloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, and CI-990 in the… 
1993
1993
In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.
In this study the intraphagocytic bioactivities of the new fluoroquinolone antimicrobial agents clinafloxacin (CI-960) and PD… 
1993
1993
Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin.
The susceptibility of anaerobic bacteria to two new fluoroquinolones, PD 131628 (the bioactive form of PD 131112 or CI-990) and… 
1993
1993
Comparative In Vitro Activity of PD 131628, the Microbiologically Active Constituent of the Prodrug CI-990 (PD 131112)
Staphylococcus spp. (122) 0.12 (MSSA, MRSA, MSSE, MRSE) Streptococcus pyogenes (73) 0.25 S. pneumoniae (24) 0.25 Enterococcus… 
1992
1992
Comparative Activity ofCiprofloxacin, Ofloxacin, Sparfloxacin, Temafloxacin, CI-960, CI-990, andWIN 57273against
(AT4140,RP64206, andPD131501), CI-960(PD127391 andAM1091)[7-(3-amino-1-pyrrolidinyl)-8-chloro-1-cyclopropyl-6fluoro-1,4-dihydro-4… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)